Coccidioidomycosis outbreaks, United States and worldwide, 1940–2015

Emerging Infectious Diseases

Volumn 24, Issue 3, 2018, Pages 417-424

  Freedman, Michael ^a   Jackson, Brendan R ^b   McCotter, Orion ^b   Benedict, Kaitlin ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ARTICLE; AWARENESS; CLINICAL FEATURE; CLINICAL OUTCOME; COCCIDIOIDOMYCOSIS; EARTHQUAKE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; GLOBAL HEALTH; HUMAN; INCIDENCE; INCUBATION TIME; LABORATORY DIAGNOSIS; OCCUPATIONAL EXPOSURE; PROPHYLAXIS; PUBLIC HEALTH; PUBLICATION; SCIENTIFIC LITERATURE; SYMPTOM; THORAX RADIOGRAPHY; UNITED STATES; COCCIDIOIDES; GEOGRAPHY; HISTORY; MICROBIOLOGY;

COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DISEASE OUTBREAKS; GEOGRAPHY; GLOBAL HEALTH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; OCCUPATIONAL EXPOSURE; UNITED STATES;

EID: 85042296933     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2403.170623     Document Type: Article

References (41)

1. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112–46. http://dx.doi.org/10.1093/cid/ciw360
2. Comrie AC. Climate factors influencing coccidioidomycosis seasonality and outbreaks. Environ Health Perspect. 2005; 113:688–92. http://dx.doi.org/10.1289/ehp.7786
3. Kolivras KN, Comrie AC. Modeling Valley fever (coccidioidomycosis) incidence on the basis of climate conditions. Int J Biometeorol. 2003;47:87–101.
4. Zender CS, Talamantes J. Climate controls on Valley fever incidence in Kern County, California. Int J Biometeorol. 2006;50: 174–82. http://dx.doi.org/10.1007/s00484-005-0007-6
5. Smith CE, Whiting EG, Baker EE, Rosenberger HG, Beard RR, Saito MT. The use of coccidioidin. Am Rev Tuberc. 1948;57:330–60.
6. Adam RD, Elliott SP, Taljanovic MS. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med. 2009;122:770–7. http://dx.doi.org/10.1016/j.amjmed.2008.12.024
7. Smith CE, Beard RR. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health Nations Health. 1946;36:1394–402. http://dx.doi.org/10.2105/AJPH.36.12.1394
8. Saubolle MA. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:301–14. http://dx.doi.org/10.1196/annals.1406.049
9. Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis) statistics. 2017 [cited 2017 Sep 7]. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html
10. Freedman M, Anderson S, Benedict K, McCotter O, Derado G, Hoekstra R, et al. Preliminary estimates of annual burden of coccidioidomycosis in the United States, 2010–2014. In: Abstracts of the Coccidioidomycosis Study Group 61st Annual Meeting in collaboration with the 7th International Coccidioidomycosis Symposium; 2017 Aug 10–13; Palo Alto (CA). Stanford (CA): Coccidioidomycosis Study Group; 2017. p. 32.
11. The University of Arizona Health Sciences, College of Medicine Tucson. Valley Fever Center for Excellence, Cocci Study Group. Proceedings of the annual CSG meetings [cited 2017 Sept 7]. http://vfce.arizona.edu/research/cocci-study-group
12. National Institute for Occupational Safety and Health. Health hazard evaluations (HHEs). 2016 [cited 2017 Dec 19]. http://www2a.cdc.gov/hhe/search.asp
13. Edwards PQ, Palmer CE. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. Dis Chest. 1957;31:35–60. http://dx.doi.org/10.1378/chest.31.1.35
14. Haley L. Compensability of, and legal issues related to, coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:129–32. http://dx.doi.org/10.1196/annals.1406.002
15. Wilken JA, Sondermeyer G, Shusterman D, McNary J, Vugia DJ, McDowell A, et al. Coccidioidomycosis among workers constructing solar power farms, California, USA, 2011–2014. Emerg Infect Dis. 2015;21:1997–2005. http://dx.doi.org/10.3201/eid2111.150129
16. Park BJ, Sigel K, Vaz V, Komatsu K, McRill C, Phelan M, et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998–2001. J Infect Dis. 2005;191:1981–7. http://dx.doi.org/10.1086/430092
17. Centers for Disease Control and Prevention. Coccidioidomycosis —United States, 1991–1992. MMWR Morb Mortal Wkly Rep. 1993;42:21–4.
18. Emery K, Hernandez K, Lancaster M, Constantine M, Jonah C, McMasters P, et al. Does 2010 signal the start of another coccidioidomycosis epidemic in Kern County? In: Proceedings of the 55th Annual Coccidioidomycosis Study Group; 2011 Apr 2; Davis (CA). Davis (CA): Coccidioidomycosis Study Group; 2011. p. 9.
19. Schneider E, Hajjeh RA, Spiegel RA, Jibson RW, Harp EL, Marshall GA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA. 1997;277:904–8. http://dx.doi.org/10.1001/jama.1997.03540350054033
20. Flynn NM, Hoeprich PD, Kawachi MM, Lee KK, Lawrence RM, Goldstein E, et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med. 1979;301:358–61. http://dx.doi.org/10.1056/NEJM197908163010705
21. Crum-Cianflone NF. Coccidioidomycosis in the U.S. military: a review. Ann N Y Acad Sci. 2007;1111:112–21. http://dx.doi.org/10.1196/annals.1406.001
22. Smith CE. Coccidioidomycosis: historical note. In: Coates JB, Hoff EC, Hoff MA, editors. Preventive medicine in World War II, Volume IV, communicable diseases, transmitted chiefly through respiratory and alimentary tracts. Washington: Office of the Surgeon General, Medical Department, United States Army; 1958. p. 285–316.
23. Armed Forces Health Surveillance Center. Historical perspective: coccidioidomycosis in the U.S. military and military-associated populations. MSMR. 2012;19:5–6.
24. Armed Forces Health Surveillance Center. Coccidioidomycosis, active component, U.S. Armed Forces, January 2000–June 2012. MSMR. 2012;19:10.
25. Armed Forces Health Surveillance Center. Brief report: the geographic distribution of incident coccidioidomycosis among active component service members, 2000–2013. MSMR. 2014;21:12–4.
26. Kritzer MD, Biddle M, Kessel JF. An outbreak of primary pulmonary coccidioidomycosis in Los Angeles County, California. Ann Intern Med. 1950;33:960–90. http://dx.doi.org/10.7326/0003-4819-33-4-960
27. Pappagianis D, Sacks HD. Outbreak of coccidioidomycosis in California prisons 2003–2004. In: Galgiani JN, Brauer RJ, editors. Proceedings of the Annual Coccidioidomycosis Study Group Meeting; 2004 Apr 3; Rosarito Beach, Mexico. Tucson (AZ): Valley Fever Center for Excellence; 2004. p. 6.
28. Hirschmann JV. The early history of coccidioidomycosis: 1892–1945. Clin Infect Dis. 2007;44:1202–7. http://dx.doi.org/10.1086/513202
29. Jensen GM. System failure: health-care deficiencies in the World War II Japanese American detention centers. Bull Hist Med. 1999;73:602–28. http://dx.doi.org/10.1353/bhm.1999.0171
30. Wheeler C, Lucas KD, Mohle-Boetani JC. Rates and risk factors for coccidioidomycosis among prison inmates, California, USA, 2011. Emerg Infect Dis. 2015;21:70–5. http://dx.doi.org/10.3201/eid2101.140836
31. California Correctional Health Care Services. Coccidioidomycosis skin test policy. 2016 [cited 2017 Dec 19]. http://www.cphcs.ca.gov/docs/imspp/IMSPP-v10-ch10.1.pdf
32. Blair JE, Chang Y-HH, Ruiz Y, Duffy S, Heinrich BE, Lake DF. Distance from construction site and risk for coccidioidomycosis, Arizona, USA. Emerg Infect Dis. 2014;20:1464–71. http://dx.doi.org/10.3201/eid2009.131588
33. California Department of Public Health. Preventing work-related Valley fever (coccidioidomycosis) [cited 2017 Dec 19]. https://www.cdph.ca.gov/Programs/CCDPHP/DEODC/OHB/HESIS/CDPH%20Document%20Library/CocciFact.pdf
34. Fisher FS, Bultman MW, Pappagianis D. Operational guidelines for geological fieldwork in areas endemic for coccidioidomycosis (Valley fever). Menlo Park (CA): US Geological Survey; 2000.
35. Hanel Jr E, Kruse RH. Miscellaneous publication 28: laboratory-acquired mycoses. Fort Detrick, Frederick (MD): Industrial Health and Safety Office, Research and Radiological Division, Department of the Army; 1967.
36. Stevens DA, Clemons KV, Levine HB, Pappagianis D, Baron EJ, Hamilton JR, et al. Expert opinion: what to do when there is coccidioides exposure in a laboratory. Clin Infect Dis. 2009;49:919–23. http://dx.doi.org/10.1086/605441
37. Engelthaler DM, Chiller T, Schupp JA, Colvin J, Beckstrom-Sternberg SM, Driebe EM, et al. Next-generation sequencing of Coccidioides immitis isolated during cluster investigation. Emerg Infect Dis. 2011;17:227–32. http://dx.doi.org/10.3201/eid1702.100620
38. Kusne S, Taranto S, Covington S, Kaul DR, Blumberg EA, Wolfe C, et al. Coccidioidomycosis transmission through organ transplantation: a report of the OPTN Ad Hoc Disease Transmission Advisory Committee. Am J Transplant. 2016;16:3562–7. http://dx.doi.org/10.1111/ajt.13950
39. Smith CE. Epidemiology of acute coccidioidomycosis with erythema nodosum (“San Joaquin” or “Valley fever”). Am J Public Health Nations Health. 1940;30:600–11. http://dx.doi.org/10.2105/AJPH.30.6.600
40. Tsang CA, Anderson SM, Imholte SB, Erhart LM, Chen S, Park BJ, et al. Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007–2008. Emerg Infect Dis. 2010;16:1738–44. http://dx.doi.org/10.3201/eid1611.100475
41. Crum NF, Lederman ER, Stafford CM, Parrish JS, Wallace MR. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004;83:149–75. http://dx.doi.org/10.1097/01. md.0000126762.91040.fd